When comparing the tumours’ HLA-A, HLA-B and β2M expression between the sHLA-negative and sHLA-positive groups, no significant differences were found (p = 0.07, p = 0.46 and p = 0.60, respectively) (Table 2). The gene discussed is B2M; the disease is neoplasm.